Assimomytis N
No ORCID on file
· 2 papers in corpus
· active 2018-2019
Top journals
Frequent coauthors
- Papahatjis D 2
- Christodoulou I 1
- Goulielmaki M 1
- Pintzas A 1
- Pappou E 1
- Pratsinis H 1
- Papadimitriou V 1
- Rozanc J 1
- Taki E 1
- Theochari I 1
2019
Development of novel bioactive compounds against KRAS and/or BRAF mutant colorectal cancer (CRC) is currently an urgent need in oncology. In addition, single or multitarget kinase inhibitors against MEK/ERK and PI3K/AKT pathways are of pote…
2018
Targeted delivery of chemotherapeutics in order to overcome side effects and enhance chemosensitivity remains a major issue in cancer research. In this context, biocompatible oil-in-water (O/W) microemulsions were developed as matrices for …